What they were paid
Altimmune Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $47,335 | — | $143,669 | $0 | $191,004 |
| FY2024 | $0 | $0 | $0 | $0 | $0 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Altimmune, Inc. DEF 14A filed March 17, 2026, accession 0001104659-26-028953, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Altimmune pays directors a $40,000 cash retainer.
Committees
FY2025 · as the proxy prints themCompensation
The rest of the Altimmune board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Catherine Sohn, Pharm D | Independent Director | $310,225 |
| Diane K. Jorkasky, M.D | Independent Director | $191,169 |
| Jerome Durso | Chair of the Board | $10,361,657 |
| John M. Gill | Independent Director | $205,294 |
| Klaus O. Schafer, M.D., MPH | Independent Director | $201,169 |
| Mitchel Sayare, Ph.D | Independent Director | $208,669 |
| Philip L. Hodges | Independent Director | $211,169 |
| Wayne Pisano | Independent Director | $208,794 |
The full Altimmune compensation record
free company briefThis page is one director within Altimmune's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat